Support Alert

Class 2 Medicines Recall: Novartis Pharmaceuticals UK, Sandimmun Oral Solution

Novartis Pharmaceuticals UK are recalling a batch of Sandimmun Oral Solution due to the presence of crystals in the solution. The crystals have been identified as the active substance (ciclosporin). The presence of crystals has been observed in some finished product packs marketed in other countries that share the same master batch as the specified UK batch. Therefore, this UK batch is recalled as a precautionary measure. Novartis Pharmaceuticals UK have confirmed no other batches of the product are impacted.

Further information, advice and details of the affected batch can be found on the MHRA website.


A day you'll remember: #RPSConf22


On Friday 11 November, we'll change how you think about pharmacy, how you work with colleagues, and how you see yourself and your future!


Join us and discover how much pharmacy is changing. It’s a day for you to listen, to learn, and to discuss - as well as to enjoy meeting all your fellow professionals.

Get inspired with us on Friday, 11 November, and discover the future of pharmacy.